Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B.

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Breast Cancer
Interventions
DRUG

Mifepristone

"At the time a patient enters the protocol, 14 pills will be given to the personnel responsible of giving the patient the medicine at her home (This was a special requirement from the Argentine Authorities).~Patients and personnel will sign the form each then she gets the medication and after that the signed form will be kept at the CRF file."

Trial Locations (1)

1617

HospitalPMVM, General Pacheco

All Listed Sponsors
collaborator

National Agency for Scientific and Technological Promotion, Argentina

OTHER

collaborator

Instituto de Biología y Medicina Experimental (IBYME-CONICET)

UNKNOWN

lead

Hospital Provincial Magdalena V. de Martínez

OTHER

NCT02651844 - Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B. | Biotech Hunter | Biotech Hunter